These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29468607)

  • 1. The Patient-Reported Information Multidimensional Exploration (PRIME) Framework for Investigating Emotions and Other Factors of Prostate Cancer Patients with Low Intermediate Risk Based on Online Cancer Support Group Discussions.
    Bandaragoda T; Ranasinghe W; Adikari A; de Silva D; Lawrentschuk N; Alahakoon D; Persad R; Bolton D
    Ann Surg Oncol; 2018 Jun; 25(6):1737-1745. PubMed ID: 29468607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robotic-assisted vs. open radical prostatectomy: A machine learning framework for intelligent analysis of patient-reported outcomes from online cancer support groups.
    Ranasinghe W; de Silva D; Bandaragoda T; Adikari A; Alahakoon D; Persad R; Lawrentschuk N; Bolton D
    Urol Oncol; 2018 Dec; 36(12):529.e1-529.e9. PubMed ID: 30236854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can online support groups address psychological morbidity of cancer patients? An artificial intelligence based investigation of prostate cancer trajectories.
    Adikari A; de Silva D; Ranasinghe WKB; Bandaragoda T; Alahakoon O; Persad R; Lawrentschuk N; Alahakoon D; Bolton D
    PLoS One; 2020; 15(3):e0229361. PubMed ID: 32130256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
    Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
    Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning to support social media empowered patients in cancer care and cancer treatment decisions.
    De Silva D; Ranasinghe W; Bandaragoda T; Adikari A; Mills N; Iddamalgoda L; Alahakoon D; Lawrentschuk N; Persad R; Osipov E; Gray R; Bolton D
    PLoS One; 2018; 13(10):e0205855. PubMed ID: 30335805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.
    Shrader-Bogen CL; Kjellberg JL; McPherson CP; Murray CL
    Cancer; 1997 May; 79(10):1977-86. PubMed ID: 9149026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective.
    Newton FJ; Burney S; Millar JL; Frydenberg M; Ng KT
    BJU Int; 2006 Jun; 97(6):1179-83. PubMed ID: 16686708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.
    Hurwitz LM; Cullen J; Kim DJ; Elsamanoudi S; Hudak J; Colston M; Travis J; Kuo HC; Rice KR; Porter CR; Rosner IL
    Cancer; 2017 Nov; 123(21):4252-4258. PubMed ID: 28678408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
    Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
    Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
    Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
    BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Prostate Cancer Treatment on the Sexual Quality of Life for Men-Who-Have-Sex-with-Men.
    Lee TK; Handy AB; Kwan W; Oliffe JL; Brotto LA; Wassersug RJ; Dowsett GW
    J Sex Med; 2015 Dec; 12(12):2378-86. PubMed ID: 26537853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
    Lehto US; Tenhola H; Taari K; Aromaa A
    Br J Cancer; 2017 Mar; 116(7):864-873. PubMed ID: 28222069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    Donovan JL; Hamdy FC; Lane JA; Mason M; Metcalfe C; Walsh E; Blazeby JM; Peters TJ; Holding P; Bonnington S; Lennon T; Bradshaw L; Cooper D; Herbert P; Howson J; Jones A; Lyons N; Salter E; Thompson P; Tidball S; Blaikie J; Gray C; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Kockelbergh R; Kynaston H; Paul A; Powell P; Prescott S; Rosario DJ; Rowe E; Davis M; Turner EL; Martin RM; Neal DE;
    N Engl J Med; 2016 Oct; 375(15):1425-1437. PubMed ID: 27626365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.